**Summary**
Eden Research plc, a UK-listed biopesticide company, announced a retail offer of new ordinary shares to raise up to £500,000. This offer is part of a larger fundraising effort to secure £10.7 million for advancing the development, registration, and commercialization of its insecticide formulation and a new fungicide targeting Late Blight in potatoes. The retail offer is open exclusively to existing shareholders in the United Kingdom, with a minimum subscription of £100 per investor. The shares are offered at 4.0 pence each, representing a 2.6% premium over the recent closing price. The offer is conditional on shareholder approval and the completion of a firm capital raising. Proceeds will support product development and scale-up operations. The offer is managed by Cavendish Capital Markets Limited, with a subscription window from February 2 to February 5, 2026, and admission to trading expected on February 19, 2026. Investors are cautioned about the risks associated with the investment, including potential capital loss and lack of liquidity.